Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes.

Biomedicines · 2023 · PMC10216597 · PMID 37239033

Europe PMC DOI

hedged sentence

0.8500

closest p · 17.0× alpha

0.8500

boldest claim

The sentences

did not reach statistical significancep = 0.85not close (p > 0.1)

HDL cholesterol slightly increased, although the difference did not reach statistical significance ( p = 0.85; Table 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.